Thus, in this study, we carried out a comprehensive analysis of AR (CAG)n and APEX1 c.444T>G polymorphisms in an Argentinian cohort of 123 PCa patients, studying their associations with clinicopathological parameters and biochemical relapse-free survival (BRFS). This evidence concerns the gene APEX1 and posterior cortical atrophy.